Kohjin Bio Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	5,074	5,206	4,770	4,742	3,947	3,137
Revenue Growth (YoY)	-1.46%	9.14%	0.59%	20.14%	25.81%	37.86%
Cost of Revenue	2,893	2,841	2,889	2,288	1,907	1,625
Gross Profit	2,181	2,365	1,881	2,454	2,040	1,512
Selling, General & Admin	1,310	1,206	1,024	1,186	1,069	-
Research & Development	168	168	240	-	-	-
Other Operating Expenses	-	-	-	-	-	801.92
Operating Expenses	1,478	1,374	1,284	1,186	1,069	801.92
Operating Income	703	991	597	1,268	971	709.8
Interest Expense	-37	-30	-22	-32	-38	-36.18
Interest & Investment Income	4	2	-	-	-	-
Earnings From Equity Investments	45	98	71	10	-29	-
Currency Exchange Gain (Loss)	-	-	6	-5	5	-
Other Non Operating Income (Expenses)	-5	3	-18	2	9	289.68
EBT Excluding Unusual Items	710	1,064	634	1,243	918	963.3
Gain (Loss) on Sale of Assets	-	1	-	-	1	-
Other Unusual Items	11	-51	-	-	3	-
Pretax Income	711	1,014	634	1,243	922	963.3
Income Tax Expense	154	220	250	414	335	266.41
Net Income to Company	-	794	384	829	587	-
Net Income	557	794	384	829	587	696.89
Net Income to Common	557	794	384	829	587	696.89
Net Income Growth	-19.63%	106.77%	-53.68%	41.23%	-15.77%	-
Shares Outstanding (Basic)	5	5	4	4	3	-
Shares Outstanding (Diluted)	5	5	4	4	3	-
Shares Change (YoY)	6.31%	21.11%	-	22.96%	-	-
EPS (Basic)	108.97	157.41	92.20	199.04	173.30	-
EPS (Diluted)	108.97	157.41	92.20	199.04	173.30	-
EPS Growth	-24.40%	70.74%	-53.68%	14.85%	-	-
Free Cash Flow	-	53	261	-	-	-
Free Cash Flow Per Share	-	10.51	62.66	-	-	-
Dividend Per Share	24.000	24.000	14.000	19.000	-	-
Dividend Growth	71.43%	71.43%	-26.32%	-	-	-
Gross Margin	42.98%	45.43%	39.43%	51.75%	51.69%	48.19%
Operating Margin	13.86%	19.04%	12.52%	26.74%	24.60%	22.63%
Profit Margin	10.98%	15.25%	8.05%	17.48%	14.87%	22.21%
Free Cash Flow Margin	-	1.02%	5.47%	-	-	-
EBITDA	1,109	1,351	896	-	-	-
EBITDA Margin	21.85%	25.95%	18.78%	-	-	-
D&A For EBITDA	405.75	360	299	-	-	-
EBIT	703	991	597	1,268	971	709.8
EBIT Margin	13.86%	19.04%	12.52%	26.74%	24.60%	22.63%
Effective Tax Rate	21.66%	21.70%	39.43%	33.31%	36.33%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.